GNOMOverviewHoldingsDividends
Fund holdings · Global X Genomics & Biotechnology ETF

GNOM holdings: all 50 positions

GNOM held 50 positions as of May 31, 2026. Guardant Health Inc is the largest at 5.59%; the top 10 are 42.5% of the fund.

Share
Download CSVGNOM fund page
How much of the fund each position is · one bar per position, largest first
GH 5.59%50 positionsDGX 0.28%
42.5%
top 10 together
5.59%
largest position
16
positions under 1%

Every position

50 of 50 · click a column to sort
GNOM’s 50 positions by weight, from the holdings filed for May 31, 2026. A weight is a share of net assets. Source: Form N-PORT filed with the SEC.
#HoldingTickerWeight ↓
1Guardant Health IncGH5.59%
2Illumina IncILMN4.82%
3Natera IncNTRA4.15%
4BioMarin Pharmaceutical IncBMRN4.09%
5Arrowhead Pharmaceuticals IncARWR4.07%
6Legend Biotech CorpLEGN4.04%
7Praxis Precision Medicines IncPRAX4.01%
8Twist Bioscience CorpTWST3.97%
9Vertex Pharmaceuticals IncVRTX3.95%
10CRISPR Therapeutics AGCRSP3.85%
11Veracyte IncVCYT3.64%
12Qiagen N.V.QGEN3.54%
13BioNTech SEBNTX3.41%
14Bio-Techne CorpTECH3.41%
15Moderna IncMRNA3.28%
1610X Genomics IncTXG3.23%
17Beam Therapeutics IncBEAM3.09%
18Eli Lilly & CoLLY2.31%
19Ultragenyx Pharmaceutical IncRARE2.25%
20Caris Life Sciences IncCAI2.03%
21Genscript Biotech Corp2.00%
22BillionToOne Inc1.97%
23Gilead Sciences IncGILD1.95%
24Astrazeneca PLC1.83%
25Sarepta Therapeutics IncSRPT1.80%
26Uniqure NVQURE1.59%
27Intellia Therapeutics IncNTLA1.59%
28Stoke Therapeutics IncSTOK1.45%
29GeneDx Holdings CorpWGS1.35%
30Danaher CorpDHR1.17%
31Bristol-Myers Squibb CoBMY1.16%
32Vir Biotechnology IncVIR1.11%
33CareDx IncCDNA1.05%
34WAVE Life Sciences Ltd1.03%
35Personalis IncPSNL0.79%
36Maravai LifeSciences Holdings IncMRVI0.51%
37Bruker CorpBRKR0.43%
38Pacific Biosciences of California IncPACB0.40%
39Benitec Biopharma IncBNTC0.38%
40Agilent Technologies IncA0.38%
41Fulgent Genetics IncFLGT0.36%
42Standard BioTools IncLAB0.35%
43Myriad Genetics IncMYGN0.35%
44Editas Medicine IncEDIT0.34%
45Prime Medicine, IncPRME0.34%
46Regenxbio IncRGNX0.33%
47Rocket Pharmaceuticals IncRCKT0.32%
48Mesa Laboratories IncMLAB0.29%
49Caribou Biosciences IncCRBU0.29%
50Quest Diagnostics IncDGX0.28%
Cash and other net assets0.10%
As of May 31, 2026. Source: Form N-PORT filed with the SEC.

The book

FundGlobal X Genomics & Biotechnology ETF
Positions50
Holdings as of (SEC N-PORT)May 31, 2026
SourceForm N-PORT filed with the SEC ↗
Top 10 together42.5%
Cash and other net assets0.10%

By country

United States96.1%
Hong Kong2.0%
United Kingdom1.8%

Share of the fund, positions only, as the fund’s SEC filing states them.

What this list is

How the list is built

Each weight is the share of net assets the fund’s SEC filing gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.

Weights are as the source states them, largest first.

Where to next
GNOM fund page→Overlap of GNOM with another fund→Which ETFs hold a company→Compare two funds→How books are read→
Where these figures came from
Form N-PORT filed with the SEC ↗SEC Form N-PORT, what a fund filed it holds ↗SEC EDGAR, full-text search of fund filings ↗

ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →

Cite this pageCitation, APA and Markdown

ETFIQ, Holdings of GNOM, data as of May 31, 2026. https://etfiq.com/funds/gnom/holdings/

Open data →

Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.